Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prokidney (PROK) Operating Expenses (2022 - 2025)

Historic Operating Expenses for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to $38.8 million.

  • Prokidney's Operating Expenses fell 2086.25% to $38.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $172.0 million, marking a year-over-year increase of 1000.29%. This contributed to the annual value of $183.8 million for FY2024, which is 2127.08% up from last year.
  • Per Prokidney's latest filing, its Operating Expenses stood at $38.8 million for Q3 2025, which was down 2086.25% from $39.9 million recorded in Q2 2025.
  • Over the past 5 years, Prokidney's Operating Expenses peaked at $66.5 million during Q1 2022, and registered a low of $20.7 million during Q2 2022.
  • Moreover, its 4-year median value for Operating Expenses was $40.1 million (2024), whereas its average is $40.6 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first plummeted by 3849.72% in 2023, then skyrocketed by 11332.92% in 2024.
  • Quarter analysis of 4 years shows Prokidney's Operating Expenses stood at $30.2 million in 2022, then fell by 19.93% to $24.2 million in 2023, then soared by 113.33% to $51.6 million in 2024, then decreased by 24.96% to $38.8 million in 2025.
  • Its Operating Expenses was $38.8 million in Q3 2025, compared to $39.9 million in Q2 2025 and $41.6 million in Q1 2025.